DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Ironmonger A. * et al. GlaxoSmithKline, Stevenage, UK and Merck & Co., Rahway, USA
Development and Scale-Up of a Manufacturing Route for the Non-nucleoside Reverse Transcriptase Inhibitor GSK2248761A (IDX-899): Synthesis of an Advanced Key Chiral Intermediate.
Org. Process Res. Dev. 2018;
22: 200-206
Access:
We do not assume any responsibility for the contents of the web pages of other providers.